Towa Pharmaceutical (OTCMKTS:TWAPF – Get Free Report) is expected to post its resultson Wednesday, November 11th. Analysts expect the company to post earnings of $0.6430 per share and revenue of $450.44 million for the quarter.
Towa Pharmaceutical Stock Performance
TWAPF stock opened at $25.98 on Wednesday. The firm has a 50 day moving average of $25.98 and a 200-day moving average of $25.61. Towa Pharmaceutical has a 12 month low of $25.71 and a 12 month high of $26.00.
About Towa Pharmaceutical
Towa Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company focused on the development, manufacture and sale of generic medicines. Its products are intended to provide alternatives to branded drugs across a range of therapeutic areas, including treatments for chronic and acute conditions.
The company is known for producing various dosage forms, including tablets, orally disintegrating tablets and other formulations designed to support patient convenience and adherence. Towa Pharmaceutical conducts pharmaceutical research and development, manufacturing, quality management and distribution through its operations and business partners.
Founded in Japan in 1951, Towa Pharmaceutical primarily serves the Japanese healthcare market and has developed a long-standing presence in the country’s generic-drug sector.
Further Reading
- Five stocks we like better than Towa Pharmaceutical
- Meta’s $100 Billion AI Financing Plan Has a Catch for Existing Shareholders
- Tower Semiconductor’s Earnings Are Soaring—So Why Is Its Stock Down More Than 50%?
- Shopify’s Small Q3 Miss Triggered a Big Sell-Off: What’s Next?
- Can Oil’s Big Rally Deliver Reliable Income? 3 Energy Plays to Watch
Receive News & Ratings for Towa Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Towa Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
